Echinocandins - An advance in the primary treatment of invasive candidiasis.

被引：58
作者：
Walsh, TJ [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 347卷 / 25期
关键词：
D O I：
10.1056/NEJMe020142
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2070 / 2072
页数：4
相关论文
共 10 条
[1]   Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice [J].
Abruzzo, GK ;
Gill, CJ ;
Flattery, AM ;
Kong, L ;
Leighton, C ;
Smith, JG ;
Pikounis, VB ;
Bartizal, K ;
Rosen, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2310-2318
[2]   Echinocandins: a new class of antifungal [J].
Denning, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (06) :889-891
[3]   The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance [J].
Kao, AS ;
Brandt, ME ;
Pruitt, WR ;
Conn, LA ;
Perkins, BA ;
Stephens, DS ;
Baughman, WS ;
Reingold, AL ;
Rothrock, GA ;
Pfaller, MA ;
Pinner, RW ;
Hajjeh, RA .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1164-1170
[4]   VASCULAR CATHETER ASSOCIATED FUNGEMIA IN PATIENTS WITH CANCER - ANALYSIS OF 155 EPISODES [J].
LECCIONES, JA ;
LEE, JW ;
NAVARRO, EE ;
WITEBSKY, FG ;
MARSHALL, D ;
STEINBERG, SM ;
PIZZO, PA ;
WALSH, TJ .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) :875-883
[5]   Comparison of caspofungin and amphotericin B for invasive candidiasis. [J].
Mora-Duarte, J ;
Betts, R ;
Rotstein, C ;
Colombo, AL ;
Thompson-Moya, L ;
Smietana, J ;
Lupinacci, R ;
Sable, C ;
Kartsonis, N ;
Perfect, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2020-2029
[6]   Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits [J].
Petraitiene, R ;
Petraitis, V ;
Groll, AH ;
Candelario, M ;
Sein, T ;
Bell, R ;
Lyman, CA ;
McMillian, CL ;
Bacher, J ;
Walsh, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2148-2155
[7]   National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans:: Frequency of occurrence and antifungal susceptibility in the SCOPE program [J].
Pfaller, MA ;
Jones, RN ;
Messer, SA ;
Edmond, MB ;
Wenzel, RP .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (02) :121-129
[8]   Practice guidelines for the treatment of candidiasis [J].
Rex, JH ;
Walsh, TJ ;
Sobel, JD ;
Filler, SG ;
Pappas, PG ;
Dismukes, WE ;
Edwards, JE .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (04) :662-678
[9]   A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis [J].
Villanueva, A ;
Gotuzzo, E ;
Arathoon, EG ;
Noriega, LM ;
Kartsonis, NA ;
Lupinacci, RJ ;
Smietana, JM ;
DiNubile, MJ ;
Sable, CA .
AMERICAN JOURNAL OF MEDICINE, 2002, 113 (04) :294-299
[10]   HOSPITAL-ACQUIRED CANDIDEMIA - THE ATTRIBUTABLE MORTALITY AND EXCESS LENGTH OF STAY [J].
WEY, SB ;
MORI, M ;
PFALLER, MA ;
WOOLSON, RF ;
WENZEL, RP .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (12) :2642-2645
1